{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-027885","form_type":"8-K","ticker":"PALI","cik":"0001357459","company_name":"PALISADE BIO, INC.","filed_at":"2022-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.311108+00:00","generated_at":"2026-06-23T04:39:29.455886+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Palisade Bio shareholders approve reverse stock split (1:10-1:50) and warrant issuance of up to 110.4M shares","bullets":["Reverse split ratio range 1-for-10 to 1-for-50 approved at Oct 4 special meeting; 45.2M votes for, 2.9M against.","Issuance of up to 110.4M shares upon exercise of Series 1 and 2 warrants approved at Oct 6 meeting; 5.5M for, 4.0M against.","Authorized share reduction from 300M to 280M approved at Oct 6 meeting; 11.5M votes for, 1.2M against.","Reverse split must be effected before 2023 annual meeting; exact ratio set by Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-027885","json":"https://secwatch.observer/filing/0001493152-22-027885.json","markdown":"https://secwatch.observer/filing/0001493152-22-027885.md","text":"https://secwatch.observer/filing/0001493152-22-027885.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357459/000149315222027885/0001493152-22-027885-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357459/000149315222027885/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T04:39:29.455886+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}